The analysis identified lenvatinib, pyrotinib, histone deacetylase 1 (HDAC1), microRNA (mir)-196, and erb-b2 receptor tyrosine kinase 2 (ERBB2) as master regulators of causal networks in diffuse- and intestinal-type GC (Figure 1). The gene discussed is ERBB2; the disease is gastric cancer.